A detailed history of Franklin Resources Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Franklin Resources Inc holds 43,420 shares of GLUE stock, worth $623,511. This represents 0.0% of its overall portfolio holdings.

Number of Shares
43,420
Previous 84,488 48.61%
Holding current value
$623,511
Previous $381,000 15.75%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 13, 2025

SELL
$4.19 - $7.49 $172,074 - $307,599
-41,068 Reduced 48.61%
43,420 $321,000
Q2 2025

Aug 12, 2025

BUY
$3.7 - $5.33 $212,894 - $306,682
57,539 Added 213.51%
84,488 $381,000
Q1 2025

May 13, 2025

SELL
$4.64 - $7.17 $2,603 - $4,022
-561 Reduced 2.04%
26,949 $125,000
Q4 2024

Feb 12, 2025

BUY
$4.8 - $10.36 $132,048 - $285,003
27,510 New
27,510 $190,000

Others Institutions Holding GLUE

About Monte Rosa Therapeutics, Inc.


  • Ticker GLUE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 46,713,900
  • Market Cap $671M
  • Description
  • Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...
More about GLUE
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.